Renal Cell Carcinoma Patient Data with Albumin-Globulin Ratio and Survival Outcomes

162 patients with localized and locally advanced clear cell renal cell carcinoma were studied to assess the prognostic role of preoperative albumin/globulin ratio. The median follow-up period was 27.5 months, with survival outcomes analyzed via Kaplan-Meier and Cox regression methods. This dataset was created by Murat Yavuz Koparal and shared via the Papers with Code platform.

Use Cases

• Predicting overall survival based on preoperative albumin/globulin ratio and pathological tumor stage.
• Analyzing disease-free survival using factors like collecting system invasion and tumor necrosis.
• Investigating correlations between low albumin/globulin ratio and clinical features such as platelet count.
• Building multivariate Cox regression models to identify independent prognostic factors for renal cell carcinoma.

Strengths

• Includes data from 162 patients, providing a specific cohort for analysis.
• Median follow-up period of 27.5 months offers longitudinal survival tracking.
• Analysis includes multiple statistical methods: Kaplan-Meier survival analysis and univariate/multivariate Cox regression.

Limitations

• Row count and column-level documentation are unknown, limiting suitability assessment.
• Last update date is unknown; freshness unverified.
• Data may reflect temporal or institutional bias inherent to a single clinical study.

Provenance

Source

Murat Yavuz Koparal via Papers with Code

Collection Method

Clinical study of patients meeting specified criteria.

Time Range

Follow-up period ranged from 6 to 89 months.